Symbols / CLVR $0.00 +0.00% Clever Leaves Holdings Inc.

Healthcare • Drug Manufacturers - Specialty & Generic • Colombia • PNK
CLVR Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Mr. Andres Fajardo
Exch · Country PNK · Colombia
Market Cap 1.05K
Enterprise Value -4.74M
Income -19.80M
Sales 17.42M
FCF (ttm) -2.25M
Book/sh 14.02
Cash/sh 3.89
Employees 296
Insider 10d —
IPO Dec 18, 2020
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -0.00
PEG —
P/S 0.00
P/B 0.00
P/C —
EV/EBITDA 0.36
EV/Sales -0.27
Quick Ratio 1.53
Current Ratio 2.40
Debt/Eq 8.62
LT Debt/Eq —
EPS (ttm) -12.63
EPS next Y -6.60
EPS Growth —
Revenue Growth 5.40%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2023-11-09
Earnings (prior) 2023-11-09
ROA -23.39%
ROE -61.27%
ROIC —
Gross Margin 37.64%
Oper. Margin -105.91%
Profit Margin -102.77%
Shs Outstand 1.75M
Shs Float 1.43M
Insider Own 0.00%
Instit Own 0.00%
Short Float 2.17%
Short Ratio 0.46
Short Interest 35.50K
52W High 0.50
vs 52W High -99.88%
52W Low 0.00
vs 52W Low 500.00%
Beta 2,217.38
Impl. Vol. —
Rel Volume 32.15
Avg Volume 786.00
Volume 25.27K
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $0.00
Price $0.00
Change 0.00%
About

Clever Leaves Holdings Inc. operates in the botanical cannabinoid and nutraceutical industries. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment cultivates, extracts, manufactures, commercializes, and distributes cannabinoid products comprising cannabis flowers, cannabidiol isolates, full spectrum and standardized extracts, and dry smokable flowers internationally. The Non-Cannabinoid segment formulates, manufactures, markets, sells, distributes, and commercializes nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States. It also produces extracted products, including isolates, crude oil extracts, and oral solutions; and tetrahydrocannabinol flowers. The company serves retail distributors, pharmaceutical and cannabis companies, and pharmacies. Clever Leaves Holdings Inc. was founded in 2017 and is based in Tocancipá, Colombia.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.00
Latest analyst target
3. DCF / Fair value
$-23.04
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.00
Low
—
High
—
Mean
—
News
RSS: Latest CLVR news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2023-12-31 2022-12-31 2021-12-31
Total Revenue
17.42
+6.14%
16.41
+6.74%
15.37
Operating Revenue
17.42
+6.14%
16.41
+6.74%
15.37
Cost Of Revenue
10.86
+18.14%
9.19
+7.33%
8.56
Reconciled Cost Of Revenue
8.99
+33.01%
6.76
-0.92%
6.83
Gross Profit
6.56
-9.16%
7.22
+5.99%
6.81
Operating Expense
22.15
-22.79%
28.69
-36.96%
45.51
Research And Development
1.14
-33.68%
1.72
+11.19%
1.55
Selling General And Administration
20.03
-22.15%
25.73
-39.03%
42.19
Selling And Marketing Expense
2.04
+7.33%
1.90
-34.92%
2.92
General And Administrative Expense
17.99
-24.49%
23.83
-39.33%
39.28
Salaries And Wages
10.23
-29.98%
14.62
-43.26%
25.76
Other Gand A
7.01
-16.53%
8.40
-32.45%
12.44
Total Expenses
33.01
-12.85%
37.88
-29.95%
54.07
Operating Income
-15.59
+27.37%
-21.47
+44.52%
-38.70
Total Operating Income As Reported
-15.59
+66.76%
-46.92
+17.98%
-57.21
EBITDA
-16.84
+55.40%
-37.75
-9.88%
-34.35
Normalized EBITDA
-12.78
+29.09%
-18.02
+48.06%
-34.69
Reconciled Depreciation
2.85
-22.44%
3.67
+4.68%
3.51
EBIT
-19.68
+52.48%
-41.42
-9.40%
-37.86
Total Unusual Items
-4.06
+79.43%
-19.73
-6007.78%
0.33
Total Unusual Items Excluding Goodwill
-4.06
+79.43%
-19.73
-6007.78%
0.33
Special Income Charges
0.00
+100.00%
-27.71
-81.77%
-15.25
Other Special Charges
—
2.26
+169.37%
-3.26
Impairment Of Capital Assets
0.00
-100.00%
19.00
+2.66%
18.51
Restructuring And Mergern Acquisition
0.00
-100.00%
6.45
0.00
Net Income
-17.90
+72.95%
-66.17
-44.70%
-45.73
Pretax Income
-19.73
+55.26%
-44.09
+1.31%
-44.68
Net Non Operating Interest Income Expense
-0.05
+98.28%
-2.67
+60.81%
-6.82
Interest Expense Non Operating
0.05
-98.28%
2.67
-60.81%
6.82
Net Interest Income
-0.05
+98.28%
-2.67
+60.81%
-6.82
Interest Expense
0.05
-98.28%
2.67
-60.81%
6.82
Other Income Expense
-4.09
+79.51%
-19.95
-2486.60%
0.84
Other Non Operating Income Expenses
-0.03
+85.91%
-0.22
-143.82%
0.50
Gain On Sale Of Security
-4.06
-150.85%
7.98
-48.78%
15.58
Tax Provision
0.07
+101.07%
-6.35
-768.84%
0.95
Tax Rate For Calcs
0.00
+45.73%
0.00
-46.63%
0.00
Tax Effect Of Unusual Items
-0.85
+70.03%
-2.84
-3253.03%
0.09
Net Income Including Noncontrolling Interests
-17.90
+72.95%
-66.17
-44.70%
-45.73
Net Income From Continuing Operation Net Minority Interest
-19.80
+47.63%
-37.80
+17.32%
-45.73
Net Income From Continuing And Discontinued Operation
-17.90
+72.95%
-66.17
-44.70%
-45.73
Net Income Continuous Operations
-19.80
+47.63%
-37.80
+17.32%
-45.73
Net Income Discontinuous Operations
1.90
+106.69%
-28.36
—
Normalized Income
-16.59
+20.67%
-20.92
+54.50%
-45.97
Net Income Common Stockholders
-17.90
+72.95%
-66.17
-44.70%
-45.73
Diluted EPS
—
-51.70
+3.18%
-53.40
Basic EPS
—
-51.70
+3.18%
-53.40
Basic Average Shares
—
1.28
+49.44%
0.86
Diluted Average Shares
—
1.28
+49.44%
0.86
Diluted NI Availto Com Stockholders
-17.90
+72.95%
-66.17
-44.70%
-45.73
Depreciation Amortization Depletion Income Statement
0.98
-20.95%
1.24
-29.81%
1.77
Depreciation And Amortization In Income Statement
0.98
-20.95%
1.24
-29.81%
1.77
Earnings From Equity Interest Net Of Tax
0.00
+100.00%
-0.06
+32.63%
-0.10
Rent And Landing Fees
0.75
-8.23%
0.81
-24.77%
1.08
Rent Expense Supplemental
0.75
-8.23%
0.81
-24.77%
1.08
Line Item Trend 2023-12-31 2022-12-31 2021-12-31
Total Assets
31.24
-40.03%
52.10
-55.15%
116.16
Current Assets
13.94
-46.89%
26.25
-56.54%
60.39
Cash Cash Equivalents And Short Term Investments
6.83
-45.13%
12.45
-66.56%
37.23
Cash And Cash Equivalents
6.83
-45.13%
12.45
-66.56%
37.23
Receivables
2.08
-51.19%
4.26
-32.44%
6.30
Accounts Receivable
0.91
-59.72%
2.25
+1.35%
2.22
Other Receivables
—
0.06
-96.59%
1.76
Taxes Receivable
1.17
-41.60%
2.01
-13.57%
2.32
Inventory
4.48
-46.62%
8.40
-45.49%
15.41
Raw Materials
1.09
-9.05%
1.20
-18.48%
1.48
Work In Process
0.09
+338.10%
0.02
-99.09%
2.31
Finished Goods
3.30
-54.06%
7.17
-38.26%
11.62
Prepaid Assets
0.48
-31.95%
0.70
-28.62%
0.98
Restricted Cash
0.07
-84.05%
0.44
-7.19%
0.47
Total Non Current Assets
17.30
-33.07%
25.85
-53.64%
55.77
Net PPE
13.15
-13.86%
15.27
-50.65%
30.93
Gross PPE
21.94
-1.98%
22.39
-38.89%
36.63
Accumulated Depreciation
-8.79
-23.50%
-7.12
-24.87%
-5.70
Properties
0.00
0.00
0.00
Land And Improvements
1.81
+0.00%
1.81
-64.34%
5.07
Buildings And Improvements
7.82
+2.08%
7.66
-42.77%
13.38
Machinery Furniture Equipment
2.21
+1.37%
2.18
-13.86%
2.53
Construction In Progress
0.16
-32.50%
0.24
-95.80%
5.71
Other Properties
9.95
-5.28%
10.50
+5.57%
9.95
Goodwill And Other Intangible Assets
2.65
-20.90%
3.35
-85.49%
23.12
Goodwill
—
—
0.00
Other Intangible Assets
2.65
-20.90%
3.35
-85.49%
23.12
Investments And Advances
0.00
-100.00%
5.68
+289.51%
1.46
Long Term Equity Investment
0.00
-100.00%
5.68
+289.51%
1.46
Other Non Current Assets
1.50
-3.35%
1.55
+496.92%
0.26
Total Liabilities Net Minority Interest
7.03
-39.90%
11.69
-73.06%
43.39
Current Liabilities
5.81
-38.35%
9.43
-65.40%
27.25
Payables And Accrued Expenses
4.91
-24.93%
6.54
-4.97%
6.88
Payables
2.06
-10.27%
2.30
-42.25%
3.98
Accounts Payable
2.06
-10.27%
2.30
-42.25%
3.98
Current Accrued Expenses
2.84
-32.89%
4.24
+46.24%
2.90
Current Debt And Capital Lease Obligation
0.88
-48.12%
1.70
-90.27%
17.51
Current Debt
0.50
+7.10%
0.47
-97.34%
17.51
Other Current Borrowings
0.50
+7.10%
0.47
-97.34%
17.51
Current Capital Lease Obligation
0.39
-68.85%
1.24
0.00
Current Deferred Liabilities
0.02
-98.13%
1.07
+64.17%
0.65
Current Deferred Revenue
0.02
-98.13%
1.07
+64.17%
0.65
Other Current Liabilities
—
0.11
-94.88%
2.21
Total Non Current Liabilities Net Minority Interest
1.22
-46.33%
2.26
-85.98%
16.14
Long Term Debt And Capital Lease Obligation
1.20
-44.10%
2.15
-71.64%
7.59
Long Term Debt
0.72
-32.39%
1.06
-85.96%
7.59
Long Term Capital Lease Obligation
0.48
-55.57%
1.09
0.00
Non Current Deferred Liabilities
—
0.00
-100.00%
8.20
Non Current Deferred Revenue
—
0.00
-100.00%
1.55
Non Current Deferred Taxes Liabilities
—
0.00
-100.00%
6.65
Other Non Current Liabilities
0.01
-89.29%
0.11
-68.89%
0.36
Stockholders Equity
24.22
-40.07%
40.41
-44.47%
72.77
Common Stock Equity
24.22
-40.07%
40.41
-44.47%
72.77
Capital Stock
0.00
0.00
0.00
Common Stock
0.00
0.00
0.00
Preferred Stock
0.00
0.00
0.00
Share Issued
1.73
+18.78%
1.45
-94.53%
26.61
Ordinary Shares Number
1.73
+18.78%
1.45
-94.53%
26.61
Additional Paid In Capital
223.02
+0.77%
221.31
+18.03%
187.51
Retained Earnings
-198.80
-9.89%
-180.91
-57.67%
-114.74
Total Equity Gross Minority Interest
24.22
-40.07%
40.41
-44.47%
72.77
Total Capitalization
24.94
-39.87%
41.47
-48.39%
80.36
Working Capital
8.13
-51.67%
16.82
-49.25%
33.15
Invested Capital
25.43
-39.35%
41.94
-57.15%
97.86
Total Debt
2.09
-45.88%
3.86
-84.63%
25.09
Capital Lease Obligations
0.87
-62.64%
2.33
0.00
Net Tangible Assets
21.56
-41.80%
37.05
-25.37%
49.65
Tangible Book Value
21.56
-41.80%
37.05
-25.37%
49.65
Investmentsin Associatesat Cost
—
—
1.46
Line Item Trend 2023-12-31 2022-12-31 2021-12-31
Operating Cash Flow
-11.51
+60.41%
-29.07
+19.78%
-36.23
Cash Flow From Continuing Operating Activities
-11.51
+60.41%
-29.07
+19.78%
-36.23
Net Income From Continuing Operations
-17.90
+72.95%
-66.17
-44.70%
-45.73
Depreciation Amortization Depletion
2.85
-22.44%
3.67
+4.68%
3.51
Depreciation
2.85
-22.44%
3.67
—
Depreciation And Amortization
2.85
-22.44%
3.67
+4.68%
3.51
Other Non Cash Items
—
28.48
+478.49%
4.92
Stock Based Compensation
0.82
-65.09%
2.34
-79.54%
11.45
Provisionand Write Offof Assets
1.36
-71.30%
4.74
+58.93%
2.98
Asset Impairment Charge
0.00
-100.00%
19.00
+1.41%
18.74
Deferred Tax
0.00
+100.00%
-6.65
-800.00%
0.95
Deferred Income Tax
0.00
+100.00%
-6.65
-800.00%
0.95
Operating Gains Losses
1.23
+122.43%
-5.49
+70.73%
-18.75
Gain Loss On Investment Securities
3.62
+140.53%
-8.94
+46.94%
-16.86
Net Foreign Currency Exchange Gain Loss
0.47
-58.55%
1.13
-11.52%
1.28
Gain Loss On Sale Of PPE
-2.86
0.00
—
Change In Working Capital
0.14
+101.50%
-9.00
+37.10%
-14.31
Change In Receivables
1.40
+437.31%
0.26
+114.10%
-1.84
Changes In Account Receivables
1.34
+583.81%
-0.28
+49.08%
-0.55
Change In Inventory
2.56
+157.40%
-4.45
+45.68%
-8.20
Change In Prepaid Assets
0.81
+325.79%
0.19
-62.45%
0.51
Change In Payables And Accrued Expense
-2.99
+40.22%
-5.00
-4.69%
-4.77
Change In Accrued Expense
-0.10
+59.27%
-0.25
+56.94%
-0.58
Change In Payable
-2.89
+39.23%
-4.75
-13.15%
-4.20
Change In Account Payable
-2.89
+39.23%
-4.75
-13.15%
-4.20
Change In Other Working Capital
-1.05
—
—
Change In Other Current Liabilities
-0.59
0.00
—
Investing Cash Flow
4.69
+293.79%
1.19
+116.37%
-7.28
Cash Flow From Continuing Investing Activities
4.69
+293.79%
1.19
+116.37%
-7.28
Net PPE Purchase And Sale
-0.03
+97.63%
-1.31
+82.06%
-7.28
Purchase Of PPE
-0.03
+97.63%
-1.31
+82.06%
-7.28
Capital Expenditure
-0.03
+97.63%
-1.31
+82.06%
-7.28
Net Investment Purchase And Sale
1.86
-25.42%
2.50
0.00
Sale Of Investment
1.86
-25.42%
2.50
0.00
Net Business Purchase And Sale
—
2.50
0.00
Net Other Investing Changes
2.86
—
—
Financing Cash Flow
0.66
-80.05%
3.29
+79.33%
1.83
Cash Flow From Continuing Financing Activities
0.66
-80.05%
3.29
+79.33%
1.83
Net Issuance Payments Of Debt
-0.48
+97.90%
-23.06
-1772.08%
1.38
Issuance Of Debt
0.00
-100.00%
0.07
-99.74%
27.92
Repayment Of Debt
-0.48
+97.91%
-23.13
+12.84%
-26.54
Long Term Debt Issuance
0.00
-100.00%
0.07
-99.74%
27.92
Long Term Debt Payments
-0.48
+97.91%
-23.13
+12.84%
-26.54
Net Long Term Debt Issuance
-0.48
+97.90%
-23.06
-1772.08%
1.38
Net Common Stock Issuance
1.34
-95.16%
27.69
0.00
Common Stock Payments
—
—
0.00
Repurchase Of Capital Stock
—
—
0.00
Proceeds From Stock Option Exercised
0.00
-100.00%
0.02
-98.45%
1.42
Net Other Financing Charges
-0.20
+85.38%
-1.36
-41.04%
-0.96
Changes In Cash
-6.16
+74.95%
-24.59
+41.01%
-41.68
Effect Of Exchange Rate Changes
0.17
+175.66%
-0.23
-175.61%
-0.08
Beginning Cash Position
12.89
-65.81%
37.70
-52.56%
79.46
End Cash Position
6.90
-46.45%
12.89
-65.81%
37.70
Free Cash Flow
-11.54
+62.01%
-30.37
+30.20%
-43.51
Interest Paid Supplemental Data
0.20
-28.07%
0.28
-42.07%
0.49
Common Stock Issuance
1.34
-95.16%
27.69
0.00
Earnings Losses From Equity Investments
0.00
-100.00%
0.06
-32.63%
0.10
Issuance Of Capital Stock
1.34
-95.16%
27.69
0.00
Sale Of Business
—
2.50
0.00
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category